1. nFOPT®
2. AI+nFOPT®

Contact-Free, Continuous Predictive Patient Monitoring

For a long time, cardiologists have primarily relied on data recorded by electrocardiogram (ECG) machines or used stethoscopes to listen to the sounds of the beating heart to make preliminary diagnoses of cardiac diseases. However, due to equipment limitations in the past, it was difficult to synchronously analyze and measure ECG and heart sound signals. Through technology licensing and collaboration with Inovise Medical, Inc. of the United States, APODX TECHNOLOGY, INC. has successfully developed the "Zhen-Tie-Xin" wearable medical device and fully mastered the world-leading coaxial automatic analysis technology for heart sounds and ECG.

General Manager Yang Zijie further stated, "This technology combines the hardware manufacturing strength of Leadtek Research Inc. with the data integration capabilities of amorRunner Cloud. We believe we can vigorously promote this detection technology, enabling more patients to receive early treatment or prevent the onset of illness, and even accurately track their recovery." It acts just like a "caring" guardian.

Multi-physiological Signal Acquisition Terminal - Zhen-Tie-Xin
1. Single-lead ECG signal: Provides analysis for arrhythmia and autonomic nervous system (HRV) health.
2. High-sensitivity heart sound collection: Provides assessment of cardiac systolic function and hemodynamics.
3. Chest wall movement/breathing sounds: Monitors respiration depth and snoring status.
4. Physical activity and posture: Tracks physical activity levels and sleep quality.
5. Wireless transmission or offline recording: Offers two usage modes—real-time monitoring or long-term recording and analysis.
6. High waterproof rating: Worry-free 24-hour wear.

"AI-Screening" is an AI-powered biomedical interpretation system developed by Precision Biotech. It accelerates the identification of cardiovascular disease biomarkers, assists doctors and patients in obtaining comprehensive systemic cardiovascular hotspot analysis reports, and provides big data-driven analytical recommendation reports. The AI system can also analyze the relationship between daily diet and cardiovascular indices. This product has won the CES Taiwan Best Product Award and has completed clinical validation across medical institutions.

"BD-CARdio" is an ECG-AI interpretation system developed by Precision Biotech. It accelerates the generation of auxiliary analysis reports for cardiovascular diseases, assists doctors and patients in obtaining analysis reports for conditions such as arrhythmia, and provides big data-driven analytical recommendation reports. This product has completed clinical validation across four medical institutions and has successively won the Innovation Research Award from the Ministry of Economic Affairs and the Taipei Biotech Award.